Gastrointestinal tumors remain a global health challenge, with high incidence and mortality. Among them, colorectal cancer (CRC) carries the heaviest ...

Fewer cases of a hospital-related superbug were reported at East Lancashire Hospitals Trust last year, recent figures show.

Clostridioides difficile (C. difficile) is a common hospital-associated bacterial infection that causes severe diarrhoea and ...

Last year as many as four million Americans consumed about $3 billion worth of probiotic supplements — living bacteria — in ...

In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for Sick Children (SickKids) have uncovered how the body's bile acids bind to ...

From Benue to the University of South Florida, Lubem Nathaniel Agbendeh is advancing vaccine innovations that could save thousands of lives threatened by hospital-acquired Clostridioides difficile ...

A low-dose antibiotic developed in Leiden may stop C. difficile infections more effectively by targeting the pathogen while ...

More cases of a hospital-related superbug were reported at the Royal Surrey County Hospital last year, recent figures show, as the number of cases also increased across England.

Retrospective studies link proton pump inhibitors to multiple conditions; however, careful analysis shows that causality ...

Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy – based on healthy bacteria – showing it can reduce recurrences of a serious gastrointestinal ...

Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.

Probiotics are capsules or pills with live microorganisms—almost always bacteria or yeast—that are supposed to confer health ...